Anna Jamroz-Wiśniewska

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Prognostic Factors

Multiple Sclerosis

Top Venues

Journal of clinical medicine

Oxidative medicine and cellular longevity

Neurologia i neurochirurgia polska

This page only lists publications with an associated author ORCID identifier.

Publications

Klaudia Sapko, Anna Jamroz-Wiśniewska, Konrad Rejdak
Novel Drugs in a Pipeline for Progressive Multiple Sclerosis. Journal of clinical medicine 11 (12) (2022)
Anna Jamroz-Wiśniewska, Radosław Zajdel, Agnieszka Słowik, Monika Marona, Marcin Wnuk, Monika Adamczyk-Sowa, Bożena Adamczyk, Anetta Lasek-Bal, Przemysław Puz, Arkadiusz Stęposz, Ewa Krzystanek, Maja Patalong-Ogiewa, Anna Pokryszko-Dragan, Sławomir Budrewicz, Dorota Koziarska, Anna Karbicka, Sławomir Wawrzyniak, Waldemar Fryze, Marzena Furtak-Niczyporuk, Konrad Rejdak
Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients. Journal of clinical medicine 10 (9) (2021)
Anna Jamroz-Wiśniewska, Jerzy Bełtowski, Grażyna Wójcicka, Halina Bartosik-Psujek, Konrad Rejdak
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients. Oxidative medicine and cellular longevity 2020 (2020)
Klaudia Sapko, Anna Jamroz-Wiśniewska, Michał Marciniec, Marcin Kulczyński, Anna Szczepańska-Szerej, Konrad Rejdak
Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors. Neurologia i neurochirurgia polska 54 (3) (2020)